Compared with free Que, Exo-Que inhibited tau phosphorylation and the formation of NFT, which could better alleviate the symptoms of AD, indicating that Exo-Que has better potential for the treatment of AD (Table 2). Here, MAPT is linked to Alzheimer disease.